Series B funding round for AAVantgarde Bio raising $140M in November 2025
Series B funding round for AAVantgarde Bio raising $140M in November 2025
| Investor | Firm Type | Partner |
|---|
Schroder AdveqLEAD | Private | — |
| Venture Capital | — |
| Corporate Venture Capital | — |
| Family Office | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Angel | Max Klement |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$205M
Top Valuation
-
AAVantgarde Bio raised $140M in a Series B round.
The round was announced on 11/01/25.
The round was led by Harry Raikes.